NAUT
Nautilus Biotechnology, Inc.
1.90$
-4.6%
vs. previous close
Closing price · As of: Oct 5, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +7.2% | +0.1% | +0.4% | +0.9% | -3.7% | +4.6% | +0.5% | -0.9% | -1.9% | -7.1% | -13.0% | – | |
| – | -1.1% | +1.3% | +5.3% | -2.9% | -1.9% | -30.6% | -21.2% | -12.5% | -1.7% | -7.4% | -15.0% | – | |
| – | -614.0% | – | – | – | – | – | – | – | – | – | – | – | |
| – | -52.7% | +56.7% | -20.9% | +38.5% | -64.2% | -13.8% | +80.8% | +5.6% | -41.6% | +109.0% | -11.0% | – | |
| – | -414.0% | – | -36.1% | -152.5% | – | -47.4% | -25.8% | -96.9% | +74.1% | +1,708.5% | -15.5% | – | |
| – | – | – | – | – | – | – | – | +0.0% | -120.7% | – | – | – | |
| – | +1,481.3% | -3.2% | +30.2% | -56.1% | +214.3% | -95.9% | +427.8% | -100.0% | – | +994.1% | -77.9% | – | |
| – | -4,143.4% | – | -113.3% | – | – | -75.9% | -78.2% | -968.1% | – | – | -165.2% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.